UPSC 2019 CIENCE ECIHNOLOGY OVERVIEW OF THE COURSE
471.6k 4-9 Amit SAINI Educator since August 2017 UPSC CSE 2017 MAINS, SSc CGL 2012 selected, UPSC EPFO Interview 20170N THE FINAL RESERVE LIST)RAS 2017 mains,SSC CPO 2015 selected, B Overview of the Course 00:01 2:27 Edit Review 16.2k 1 Followers Following Courses 48 Follow Share Write your review here Plus courses (Hindi) Stone Age to Sultanate Part II Plus AMIT SAINI Enroll 109 Complete Course on Ethics & Integrity: Detailed GS Done Paper IV Amit SAINI Apply by Oct 31 49(10 ratings) Write a review 75,400 All lessons All lessons All courses (48) o1 Overview of the Course in Hind) 2m 26 ENGLISH Crash Course A beginners Guide for Ethics and Integrity UPSC 2019 5.0 (10 ratings) 5 lessons 1 hours of learning Save 114
7 14.0067 Nitrogen
AMI https://unacademy.com/user/talktoamitsaini DUPSC Civil Service Mains 2017 Rajasthan Civil Services Mains DUPSC EPFO Enforcement Officer 2017 2017 (finally selected ; interview panel: ALKA SIROHI madam's) OSSC CGLE 2012 (finally selected) DSSC CPO 2015 (finally selected) unacalemy
CSE 201 2 MCO. FIFTH EDITION @ o ZORPORATE BEST PRACTICES OMITTES ROLES MANAGEMENT GOVERNANCE STAF MINIVALUES NISTRATION INDIAN POLITY Detailed Explamathin IN
Choose correct regarding India Health Fund 1. it's the fund created by Ministry of healthand family welfare's DEPT.OF HEALTH & FAMILY WELFARE 2. Its created to end AIDS by 2030 in india 3. Global Fund created by World Bank is supporting IHF in its goals. (A)1 & 2 (B)Only 3 (C)1 &3 (D)None
Choose correct regarding India Health Fund 1. it's the fund created by Ministry of health OF HEALTH& FAMILY WELFARE 2. Its created to end AIDS by 2030 in india 3. Global Fund created by World Bank is supporting IHF in its goals. (A)1 & 2 (B)Only 3 (C)1 &3 (D)None
.The India Health Fund (HF). a collaborative initiative led by the Tata Trusts, endeavours to leverage the power of collective impact to eradicate tuberculosis (TB) by 2025 and malaria by 2030 from India. . The Tata Trusts partners Indian philanthropists and international and local donor agencies to support innovations and technologies designed to combat TB and malaria. IHF supplements and augments Government of India's (Gol) efforts to fight the epidemics. IHF incorporated as Confluence for Health Action and Transformation Foundation, is a section 8 company registered under the Companies Act 2013. It is seeded by Tata Trusts with strategic support from the Global Fund.
Why TB and Malaria . TB and malaria, together, account for over 4.23 lakh (0.42 million) .With over 8.5 million TB patients, the country accounts for 25 - In 2016, a staggering 1.9 million TB cases were reported including deaths annually in India alone. percent of the global TB burden 0.8 million new infectious cases. The economic cost of TB to the Indian economy has been pegged at US$3 billion (over Rs13,000 crore) annually
Vision IHF envisages strengthening the health ecosystem by bridging the gap between lab to last mile population and translating the proof of concepts into impact. IHF aims to infuse contributions and strengthen capabilities to ultimately reduce human suffering by saving lives, reducing incidence and mitigation out of pocket expenditure.
Innovation in TB and malaria Tuberculosis and malaria are endemic diseases in lndia accounting for over 4.23 lakh (0.42 million) deaths annually. Innovative and 'out of the box' products and processes are needed to eliminate the diseases in the next decade. India Health Fund (IHF) aims to anchor such validated innovations and enable them to reach scale. TUBERCULOSIS MALARIA HF collaborates with donors and investors to share investment decisions regarding raising and deployment of USD150 miltion to support strategic projects and solutions aimed at eliminaion of TB and malaria. Contributions from varied sources can be pooled as corpus or forspecific areas
The Global Fund is the world's largest financier of AIDS, TB, and malaria prevention, treatment, and care programs. As of July 2018, the organization had disbursed more than USD 38 billion to support these programs.According to the organization, in 2017 it financed the distribution of 197 million insecticide-treated nets to combat malaria, provided anti-tuberculosis treatment for 5 million people, supported 17.5 million people on antiretroviral therapy for AIDS, and since its founding saved 27 million lives worldwide
HOW IT WORKS WE RAISE THE MONEY The Global Fund raises and invests nearly US$4 billion a year to support programs run by local experts in more than 100 countries. The money comes 95 percent from donor governments and 5 percent from the private sector and foundations. COUNTRIES MAKE INVESTMENT DECISIONS OVERSIGHT IN ACTION Local Fund Agents in each country monitor implementa- tion of grants. The Global Fund's Office of the Inspector General conducts audits and investigation:s. A Country Coordinating Mechanism made up of representatives of people whose lives are affected by the three diseases, medical experts, government and civil society meets and develops a plan to fight the diseases in their community LOCAL EXPERTS IMPLEMENT 4 WE REVIEW AND APPROVE An independent panel of experts reviews the plan to determine if it will achieve results. The panel may request changes to the plan. Once finalized, it goes to the Global Fund's Board for approval. Local experts and partners use grant money to deliver programs. Impact is continuously monitored and evaluated.
The NSP for TB elimination 2017-2025 The NSP for TB elimination 2017 25 is a framework to quide the activities of all stakeholders including the national and state governments, development partners, civil society organizations, international agencies, research institutions, private sector, and many others whose workis relevant to TB elimination in India The NSP 2017-2025 which builds on the success and learnings of the last NSP, and articulates the bold and innovative steps required to move towards TB elimination, is a 3 year costed plan and a 8 year strategy document. It provides goals and strategies for the country's response to the disease during the period 2017 to 2025 and aims to direct the attention of all stakeholders on the most important interventions or activities that the RNTCP believes will bring about significant changes in the incidence, prevalence and mortality of TB. These strategies and interventions are in addition to the processes and activities already ongoing in the country
UPSC CSE 2017 MAINS, SSC CGL 2012 selected , UPSC EPFO Interview 2017(IN THE FINAL RESERVE LIST ),RAS 2017 mains,SSC CPO 2015 selected, B.